C&EN5m
Pfizer readies its next-generation COVID-19 antiviral
An alternative to Paxlovid, the only antiviral pills approved by the US Food and Drug Administration to treat COVID-19, is on ...
C&EN16m
Building a better COVID-19 vaccine
One avenue for new vaccine development is mucosal vaccines. In theory, dosing the vaccine directly into the respiratory tract ...
PhillyVoice2h
Five years after the COVID-19 pandemic began, the U.S. remains vulnerable to another crisis
The government's response to the coronavirus fueled vaccine skepticism and backlash to public health mandates. New strategies ...
BioSpace3h
Novavax Applies Lessons Learned From Turbulent COVID-19 Experience
As sales of its COVID vaccine plummet, Novavax is looking ahead toward other novel vaccines, brought to market with the help ...
Former Pfizer R&D chief Mikael Dolsten joins Immunai’s board of directors
Mikael Dolsten, M.D., Ph.D., to its Board of Directors. Dolsten, who served as Pfizer’s chief scientific officer and ...